The latest News Headlines from the Scientific, Research and HighTech world

Články z NYT > ScienceBydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval

27. 1 2012 (23:34)

The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the drug might contribute to heart rhythm abnormalities.